Did institutional whale Bridgewater Associates, LP accumulate AMGN shares in Q2 2026?
Did institutional whale Bridgewater Associates, LP accumulate AMGN shares in Q2 2026?
Official SEC Form 13F-HR institutional disclosures filed with EDGAR confirm that leading asset manager Bridgewater Associates, LP reported an active equity position of 21,869 shares in AMGEN INC (ticker AMGN) for the reporting period ending 2026-06-30, representing an aggregate portfolio valuation of $7,919,202.00. Under federal securities regulations, investment managers exercising discretion over $100M+ in 13(f) securities must disclose quarterly holdings within 45 days of quarter-end. Independent analysts assess whether Bridgewater Associates, LP's capital allocation correlates with strategic supply-chain advantages, proprietary margin expansion, or regulatory approvals in the BIOTECH_FDA sector.
Verified Quantitative Data
| Metric | Value |
|---|---|
| Value | $7.92M |
| Shares | 21869 |
Primary Source Record
This fact is compiled from public federal disclosure records. Explore the underlying dataset on the Federal Contract Explorer and the Capitol Trades leaderboard.
Data intelligence from public filings — not investment advice.